Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12903650 | 0.85 | BCHE (0.83) | ACHEBCHE | |
| SCHEMBL13043246 | 0.83 | BCHE (0.50) | ACHEBCHE | |
| SCHEMBL11148155 | 0.82 | BCHE (0.70) | ACHEBCHE | |
| SCHEMBL20151718 | 0.81 | BCHE (1.00) | ACHEBCHE | |
| 1-Ethylquinolonium SCHEMBL309459 | 0.81 | ACHE (0.63) | ACHEBCHE | |
| SCHEMBL10005295 | 0.81 | BCHE (1.00) | ACHEBCHE | |
| SCHEMBL250421 | 0.81 | ACHE (0.69) | ACHEBCHE | |
| SCHEMBL4887020 | 0.79 | BCHE (1.00) | ACHEBCHE | |
| 1-Ethylquinolonium SCHEMBL10655763 | 0.79 | ACHE (0.64) | ACHEBCHE | |
| 1-Ethylquinolonium SCHEMBL18804795 | 0.79 | ACHE (0.61) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | ACHE 4640/4885BCHE 4876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.